These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23063887)

  • 41. From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.
    Serretti A; Artioli P
    Psychopharmacology (Berl); 2004 Aug; 174(4):490-503. PubMed ID: 14997279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A synthetic method to assay adhesion-family G-protein coupled receptors. Determination of the G-protein coupling profile of ADGRG6(GPR126).
    Lizano E; Hayes JL; Willard FS
    Biochem Biophys Res Commun; 2021 Jan; 534():317-322. PubMed ID: 33248691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.
    Gilchrist A
    Trends Pharmacol Sci; 2007 Aug; 28(8):431-7. PubMed ID: 17644194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superagonism at G protein-coupled receptors and beyond.
    Schrage R; De Min A; Hochheiser K; Kostenis E; Mohr K
    Br J Pharmacol; 2016 Oct; 173(20):3018-27. PubMed ID: 26276510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective.
    Thompson MD; Takasaki J; Capra V; Rovati GE; Siminovitch KA; Burnham WM; Hudson TJ; Bossé Y; Cole DE
    Mol Diagn Ther; 2006; 10(6):353-66. PubMed ID: 17154652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. G-protein-coupled receptor signaling through Gpr176, Gz, and RGS16 tunes time in the center of the circadian clock [Review].
    Goto K; Doi M; Wang T; Kunisue S; Murai I; Okamura H
    Endocr J; 2017 Jun; 64(6):571-579. PubMed ID: 28502923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.
    Seifert R; Dove S
    Mol Pharmacol; 2009 Jan; 75(1):13-8. PubMed ID: 19001067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combinatorial expression of GPCR isoforms affects signalling and drug responses.
    Marti-Solano M; Crilly SE; Malinverni D; Munk C; Harris M; Pearce A; Quon T; Mackenzie AE; Wang X; Peng J; Tobin AB; Ladds G; Milligan G; Gloriam DE; Puthenveedu MA; Babu MM
    Nature; 2020 Nov; 587(7835):650-656. PubMed ID: 33149304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts.
    Liebmann C
    Curr Pharm Des; 2004; 10(16):1937-58. PubMed ID: 15180530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. G-Protein Dependent Signal Transduction and Ubiquitination in Dictyostelium.
    Pergolizzi B; Bozzaro S; Bracco E
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29048338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allosteric modulation of a chemogenetically modified G protein-coupled receptor.
    Abdul-Ridha A; Lane JR; Sexton PM; Canals M; Christopoulos A
    Mol Pharmacol; 2013 Feb; 83(2):521-30. PubMed ID: 23197649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Designer G Protein-Coupled Receptors to Dissect Metabolic Pathways.
    Wess J
    Trends Endocrinol Metab; 2016 Sep; 27(9):600-603. PubMed ID: 27381463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of neuronal pH by the metabotropic Zn(2+)-sensing Gq-coupled receptor, mZnR/GPR39.
    Ganay T; Asraf H; Aizenman E; Bogdanovic M; Sekler I; Hershfinkel M
    J Neurochem; 2015 Dec; 135(5):897-907. PubMed ID: 26375174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of designer receptors exclusively activated by designer drugs (DREADDs) using directed molecular evolution.
    Pei Y; Dong S; Roth BL
    Curr Protoc Neurosci; 2010 Jan; Chapter 4():Unit 4.33. PubMed ID: 20066658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenetic Predictors of Response.
    Hertz DL; Rae JM
    Adv Exp Med Biol; 2016; 882():191-215. PubMed ID: 26987536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors.
    Bhatnagar A; Sheffler DJ; Kroeze WK; Compton-Toth B; Roth BL
    J Biol Chem; 2004 Aug; 279(33):34614-23. PubMed ID: 15190056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of GPCR dimerisation/oligomerisation in receptor signalling.
    Milligan G; Canals M; Pediani JD; Ellis J; Lopez-Gimenez JF
    Ernst Schering Found Symp Proc; 2006; (2):145-61. PubMed ID: 17703581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
    Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
    Elife; 2020 Feb; 9():. PubMed ID: 32096468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Live Cell Imaging and Optogenetics-Based Assays for GPCR Activity.
    Meshik X; Gautam N
    Methods Mol Biol; 2021; 2268():207-221. PubMed ID: 34085271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorophore-assisted light inactivation produces both targeted and collateral effects on N-type calcium channel modulation in rat sympathetic neurons.
    Guo J; Chen H; Puhl HL; Ikeda SR
    J Physiol; 2006 Oct; 576(Pt 2):477-92. PubMed ID: 16873413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.